Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 108 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,958,815 | -19.7% | 2,194,278 | 0.0% | 0.75% | -22.7% |
| Q2 2023 | $14,899,148 | +35.5% | 2,194,278 | 0.0% | 0.98% | +38.8% |
| Q1 2023 | $10,993,333 | +2.7% | 2,194,278 | 0.0% | 0.70% | +10.7% |
| Q4 2022 | $10,708,077 | -66.2% | 2,194,278 | 0.0% | 0.64% | -65.5% |
| Q3 2022 | $31,641,000 | -4.7% | 2,194,278 | 0.0% | 1.84% | -33.4% |
| Q2 2022 | $33,199,000 | +27.4% | 2,194,278 | 0.0% | 2.76% | +39.8% |
| Q1 2022 | $26,068,000 | -26.7% | 2,194,278 | 0.0% | 1.98% | -4.8% |
| Q4 2021 | $35,569,000 | -43.2% | 2,194,278 | 0.0% | 2.08% | -44.0% |
| Q3 2021 | $62,625,000 | -15.6% | 2,194,278 | 0.0% | 3.71% | -13.2% |
| Q2 2021 | $74,167,000 | +11.8% | 2,194,278 | 0.0% | 4.28% | +7.2% |
| Q1 2021 | $66,355,000 | -38.9% | 2,194,278 | 0.0% | 3.99% | -38.3% |
| Q4 2020 | $108,639,000 | +29.0% | 2,194,278 | 0.0% | 6.47% | +3.5% |
| Q3 2020 | $84,238,000 | -11.1% | 2,194,278 | 0.0% | 6.25% | +4.5% |
| Q2 2020 | $94,793,000 | +65.5% | 2,194,278 | 0.0% | 5.98% | +12.8% |
| Q1 2020 | $57,271,000 | -16.5% | 2,194,278 | 0.0% | 5.30% | +7.2% |
| Q4 2019 | $68,571,000 | +25.0% | 2,194,278 | +4.3% | 4.94% | -0.3% |
| Q3 2019 | $54,837,000 | +13.9% | 2,104,278 | 0.0% | 4.96% | +12.1% |
| Q2 2019 | $48,125,000 | -12.7% | 2,104,278 | 0.0% | 4.42% | -16.8% |
| Q1 2019 | $55,153,000 | +28.9% | 2,104,278 | 0.0% | 5.32% | -0.3% |
| Q4 2018 | $42,801,000 | -23.4% | 2,104,278 | 0.0% | 5.33% | +7.0% |
| Q3 2018 | $55,890,000 | – | 2,104,278 | – | 4.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
| Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
| MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
| Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
| Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
| Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
| Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
| ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
| Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
| Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |